AAAAAA
Results:
1-14
|
Results: 14
Authors:
Levy, V
Porcher, R
Leblond, V
Fermand, JP
Cazin, B
Maloisel, F
Harousseau, JL
Remenieras, L
Guibon, O
Chevret, S
Citation: V. Levy et al., Evaluating treatment strategies in advanced Waldenstrom macroglobulinemia:use of quality-adjusted survival analysis, LEUKEMIA, 15(9), 2001, pp. 1466-1470
Authors:
Costello, R
Sainty, D
Bouabdallah, R
Fermand, JP
Delmer, A
Divine, M
Marolleau, JP
Gastaut, JA
Olive, D
Rousselot, P
Chaibi, P
Citation: R. Costello et al., Primary plasma cell leukaemia: a report of 18 cases, LEUK RES, 25(2), 2001, pp. 103-107
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization
Authors:
Dosquet, C
Chen, Y
Makke, J
Miclea, JM
Coudert, MC
Marolleau, JP
Fermand, JP
Cottu, P
Lotz, JP
Benbunan, M
Citation: C. Dosquet et al., Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization, TRANSFUSION, 41(2), 2001, pp. 206-212
Authors:
Leblond, V
Levy, V
Maloisel, F
Cazin, B
Fermand, JP
Harousseau, JL
Remenieras, L
Porcher, R
Gardembas, M
Marit, G
Deconinck, E
Desablens, B
Guilhot, F
Philippe, G
Stamatoullas, A
Guibon, O
Citation: V. Leblond et al., Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease, BLOOD, 98(9), 2001, pp. 2640-2644
Authors:
Bachmeyer, C
Guillemette, J
Blum, L
Turc, Y
Dhote, R
Fermand, JP
Aractingi, S
Citation: C. Bachmeyer et al., Telangiectasia macularis eruptiva perstans and multiple myeloma, J AM ACAD D, 43(5), 2000, pp. 972-974
Authors:
Brouet, JC
Chedeville, A
Fermand, JP
Royer, B
Citation: Jc. Brouet et al., Study of the B cell memory compartment in common variable immunodeficiency, EUR J IMMUN, 30(9), 2000, pp. 2516-2520
Authors:
Fermand, JP
Brouet, JC
Citation: Jp. Fermand et Jc. Brouet, Heavy-chain diseases, HEMAT ONCOL, 13(6), 1999, pp. 1281
Authors:
Fermand, JP
Brechignac, S
Citation: Jp. Fermand et S. Brechignac, The role of autologous stem cell transplantation in the management of multiple myeloma, PATH BIOL, 47(2), 1999, pp. 199-202
Authors:
Azoulay, E
Recher, C
Alberti, C
Soufir, L
Leleu, G
Le Gall, JR
Fermand, JP
Schlemmer, B
Citation: E. Azoulay et al., Changing use of intensive care for hematological patients: the example of multiple myeloma, INTEN CAR M, 25(12), 1999, pp. 1395-1401
Authors:
Lefrere, F
Makke, J
Fermand, JP
Marolleau, JP
Dal Cortivo, L
Alberti, C
Mouton, V
Benbunan, M
Miclea, JM
Citation: F. Lefrere et al., Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma, BONE MAR TR, 24(5), 1999, pp. 463-466
Authors:
Marolleau, JP
Dal Cortivo, L
Mills, B
Fermand, JP
Miclea, JM
Lotz, JP
Gisselbrecht, C
Benbunan, M
Citation: Jp. Marolleau et al., Enrichment of peripheral blood CD34(+) cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptidereleasing agent, BONE MAR TR, 23(8), 1999, pp. 819-826
Authors:
Aractingi, S
Bachmeyer, C
Prost, C
Caux, F
Flageul, B
Fermand, JP
Citation: S. Aractingi et al., Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders, MEDICINE, 78(4), 1999, pp. 228-235
Authors:
Rousselot, P
Labaume, S
Marolleau, JP
Larghero, J
Noguera, MH
Brouet, JC
Fermand, JP
Citation: P. Rousselot et al., Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines andin plasma cells from myeloma patients, CANCER RES, 59(5), 1999, pp. 1041-1048
Authors:
Mariette, X
Zagdanski, AM
Guermazi, A
Bergot, C
Arnould, A
Frija, J
Brouet, JC
Fermand, JP
Citation: X. Mariette et al., Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma, BR J HAEM, 104(4), 1999, pp. 723-729
Risultati:
1-14
|